e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Pulmonary embolism
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary tromboembolism (PE) in elderly patients. Mortality and hemorragic complications
S. Pedrero, F. Uresandi, V. Cabriada, N. Marina, M. Alfonso, M. Inchausti, P. Sobradillo, L. Garcia (Baracaldo, Spain)
Source:
Annual Congress 2009 - Pulmonary embolism
Session:
Pulmonary embolism
Session type:
Thematic Poster Session
Number:
3869
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pedrero, F. Uresandi, V. Cabriada, N. Marina, M. Alfonso, M. Inchausti, P. Sobradillo, L. Garcia (Baracaldo, Spain). Pulmonary tromboembolism (PE) in elderly patients. Mortality and hemorragic complications. Eur Respir J 2009; 34: Suppl. 53, 3869
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Diagnosis and treatment of chronic pulmonary embolism
Related content which might interest you:
Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF)
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018
Prevalence of relapses and chronic thromboembolic pulmonary hypertension (CTEPH) in patients with pulmonary embolism (PE)
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Characteristics of pulmonary embolism in elderly patients.
Source: International Congress 2017 – Pulmonary embolism
Year: 2017
Factors related with complications in patients with pulmonary embolism
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005
Recurrence and bleeding in the extended treatment of patients with pulmonary embolism (PE) and cancer
Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism
Year: 2018
Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021
Analysis of long-term survival of patients diagnosed of pulmonary embolism (PE)
Source: Annual Congress 2006 - Pulmonary embolism
Year: 2006
Survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Eur Respir J 2005; 26: Suppl. 49, 272s
Year: 2005
Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)?
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Pulmonary thromboembolism as the cause of death in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 483s
Year: 2001
Factors influencing mortality in ICU patients with suspected massive pulmonary embolism
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018
Short-term mortality in patients with acute symptomatic pulmonary embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009
Hemorrhagic complications of treatment in patients with pulmonary embolism
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept